newsfilter
← Latest News
GlobeNewswire·

Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Announces Strategic Pivot to Focus on Cell Therapy Programs Receives FDA Clearance for IND to Expand CD19 CAR-NKT ANCHOR to a Multi-center Study Implementing Significant Cost Reduction Plan Targeting >50% Reduction in Operating Expenses Pl